Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: BioLife Solutions Inc., 3 years.
BioLife Solutions Inc.
Director
Cerus Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioLife Solutions Inc. August 20, 202598.9%
-
BioLife Solutions Inc. August 1, 202497.9%
-
BioLife Solutions Inc. July 21, 202399.0%
-
Cerus Corporation June 7, 202386.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 24, 2026 | BioLife Solutions Inc. | Grant or award | +8,170 | — | — |
| Jun 3, 2025 | Cerus Corporation | Grant or award | +60,000 | — | — |
| Mar 18, 2025 | BioLife Solutions Inc. | Grant or award | +6,876 | — | — |
| Feb 3, 2025 | Allogene Therapeutics Inc. | Open-market sale | −14,746 | $1.71 | $25,216 |
| Jun 5, 2024 | Cerus Corporation | Grant or award | +40,000 | $5.00 | $200,000 |
| Apr 22, 2024 | Allogene Therapeutics Inc. | Shares withheld for tax | −17,360 | $3.47 | $60,239 |
| Mar 8, 2024 | BioLife Solutions Inc. | Grant or award | +11,264 | — | — |
| Jan 25, 2024 | Allogene Therapeutics Inc. | Grant or award | +96,600 | — | — |
| Nov 1, 2023 | BioLife Solutions Inc. | Grant or award | +495 | — | — |
| Oct 1, 2023 | BioLife Solutions Inc. | Grant or award | +362 | — | — |
| Jun 7, 2023 | Cerus Corporation | Grant or award | +40,000 | $5.00 | $200,000 |
| Apr 24, 2023 | Allogene Therapeutics Inc. | Grant or award | +186,219 | — | — |
| Jan 3, 2023 | BioLife Solutions Inc. | Grant or award | +10,187 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.